Arcturus Therapeutics Holdings Inc (ARCT)
Healthcare
Biotechnology
6.00 $
+4.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Who owns Arcturus Therapeutics Holdings Inc (ARCT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.0% of the shares are freely tradable; institutional investors hold 80.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
80.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
8.0%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
92.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
30.7%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
28Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Federated Hermes Inc | 11.62 | 3,303,640 | +0.0 | 03/31/2026 |
| ARK Investment Management LLC | 9.74 | 2,769,518 | +6.1 | 03/31/2026 |
| BlackRock Inc | 9.19 | 2,613,281 | -0.2 | 03/31/2026 |
| Amova Asset Management Americas, Inc | 8.05 | 2,288,935 | +12.9 | 03/31/2026 |
| Sumitomo Mitsui Trust Group Inc | 8.05 | 2,288,935 | +12.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Genomic Revolution | 9.69 | 2,754,707 | +4.6 | 06/30/2026 |
| ARK Genomic Revolution ETF | 9.63 | 2,737,727 | +0.1 | 07/29/2026 |
| Federated Hermes Kaufmann R | 7.29 | 2,072,500 | +0.0 | 03/31/2026 |
| Federated Hermes Kaufmann Growth | 7.29 | 2,072,500 | +0.0 | 03/31/2026 |
| Amova ARK Pstv Chg Innovt P JPY Acc | 6.07 | 1,725,898 | -7.6 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.